Bob D’Elia has over 40 years biopharmaceutical experience holding positions as president/ owner YPEX Technologies LLC, vice president life sciences (Integrated Engineering Services, Process Engineers, Inc.), senior director of operations (HYSEQ genomics and AXYS pharmaceuticals), director of life science operations (Eichleay Engineers and Turner Construction), senior manager – Kenneth Leventhal (Ernst & Young), senior validation/facility engineer (Rhone-Poulenc Rorer), validation & technical services coordinator (Genentech Inc.), and process engineer (Bayer Laboratories). He has focused on design, procurement, engineering, construction, startup, and validation of numerous sophisticated facilities, as well as being instrumental in obtaining FDA approvals. He has been involved in over 2.5 million square feet and $370 million in life science construction over the years.
Bob has completed extensive undergraduate studies in biochemistry, earned a Bachelor of Science in business management and a masters degree in business administration.
DOD Rocky Flats
Syntex Labs
HYSEQ, Inc.
MedImmune
AXYS Pharm
Sterling Drug
US Army (Presidio)
BioMed Realty
Genentech, Inc.
Bayer Laboratories
IMPAX
Abbott Labs
Applied Immune Sciences
BioRad
Genentech, Inc.